TESS LEE: Open Payments
NPI 1396230926 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 25 payments from 10 companies in 2025. Trend: 2023 $900 · 2024 $413 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $215 |
| Lilly USA, LLC | 3 | $57 |
| PFIZER INC. | 2 | $51 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| TMS NeuroHealth Centers Inc. | 1 | $16 |
Products named: MOUNJARO, PREVNAR 20, INSPIRE, Cologuard Collection Kit, Yeztugo, STRENSIQ, GARDASIL 9, QULIPTA.
Industry payments across MD — which companies pay providers there.
